Nautilus Biotechnology, Inc.

Developing a proteomics platform for single-molecule analysis to advance life sciences research.

NAUT | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 2701 EASTLAKE AVE EAST, 98102 SEATTLE
Website:: https://www.nautilus.bio/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Nautilus Biotechnology, Inc. is a development-stage life sciences company focused on revolutionizing the field of proteomics. The company is creating a platform to analyze and quantify the human proteome with single-molecule resolution at a massive scale. Its proprietary technology leverages a method called Iterative Mapping to provide high-resolution views of billions of individual protein molecules and their modified forms (proteoforms). Nautilus aims to democratize proteomics by offering an integrated system with accessible workflows and cloud-based analysis tools. The platform is designed to accelerate breakthroughs in drug discovery, biomarker identification, and fundamental biological research by providing clearer insights into the mechanisms of health and disease.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nautilus Biotechnology, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nautilus Biotechnology, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Nautilus Biotechnology, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
LAMAR ADVERTISING CO/NEW A leading OOH advertising REIT with billboards, transit, and airport displays in the US & Canada.	United States of America	LAMR
Larimar Therapeutics, Inc. Clinical-stage biotech developing protein therapies for rare diseases like Friedreich's ataxia.	United States of America	LRMR
LEAP THERAPEUTICS, INC. Clinical-stage biopharma developing targeted immuno-oncology antibody therapies for cancer.	United States of America	LPTX
Lidds AB Develops oncology drugs using a technology for local, controlled, and sustained drug release.	Sweden	LIDDS
LigaChem Biosciences Inc. Advancing a next-gen ADC platform to develop innovative medicines for unmet needs.	South Korea	141080
LIGAND PHARMACEUTICALS INC Acquires drug royalties and licenses proprietary technologies to biopharmaceutical partners.	United States of America	LGND
LIKE,Inc. Provides comprehensive lifestyle support in childcare, human resources, and nursing care services.	Japan	2462
Linical Co., Ltd. Global CRO providing full-service drug development support for biopharma companies.	Japan	2183
Linkers Corporation A technology matchmaking platform for manufacturers to solve challenges and foster innovation.	Japan	5131
Lipidor AB Develops topical skin treatments by reformulating drugs with a lipid-based delivery platform.	Sweden	LIPI